UNSPSC 51473003: Cetrimonium

This classification denotes a topical anti-infective agent with the molecular formula C19H42N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z7FF1XKL7A, chemically known as 1-hexadecanaminium, n,n,n-trimethyl-, chloride but generally known as cetrimonium, which bears US NIH Compound Identifier 2681. European Medicines Agency schedules Cetrimonium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01174MIG.

UNSPSC 51473003 Cetrimonium, a Commodity code, describes chemical surfactants and cleaning agents that state and local governments procure as consumable supplies for janitorial, operational, and pharmaceutical applications. Recent solicitations show the code capturing both facility maintenance supplies and pharmaceutical-grade products distributed through regulated wholesaler networks, indicating broader use than the cetrimonium compound name alone suggests. Issuing bodies include county governments and multi-state cooperative purchasing alliances. Hillsborough County Board of County Commissioners, for example, solicited janitorial and operational supplies via ITB2600319 in July 2026 to support 47 fire stations operating continuously, with an estimated contract value of $765,679.84 for a one-year term and a delivery requirement of ten days standard or five business days emergency.

Activity spans Florida and multi-state cooperative frameworks anchored in Minnesota. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 in January 2026 seeking generic pharmaceuticals and over-the-counter products for distribution across participating state and local government facilities including Oregon, with proposals due March 26, 2026 and contract performance beginning July 1, 2026. The MMCAP procurement requires vendors to supply through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), maintain cGMP and DSCSA compliance, carry liability insurance of up to $5,000,000, and accept a 3 percent administrative fee on all purchases. Awards will be made as sole, dual, or multi-awards based on therapeutic considerations and member-specific needs.